Progression of Coronary Atherosclerosis in MACS

MACS 中冠状动脉粥样硬化的进展

基本信息

  • 批准号:
    9269250
  • 负责人:
  • 金额:
    $ 70.62万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-08-07 至 2021-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Observational studies suggest that HIV infection is associated with an increased incidence of cardiovascular disease (CVD) events, including coronary heart disease and sudden cardiac death (SCD), compared to the general population; however, the specific mechanisms leading to this increased risk are not well defined. The Multicenter AIDS Cohort Study (MACS) is an observational cohort study of men who have sex with men (MSM) that includes both HIV-infected (HIV+) and -uninfected (HIV-) participants. We have measured subclinical coronary atherosclerosis by coronary computed tomography angiography (CCTA) in 764 men in the MACS. We found a greater prevalence and extent of non-calcified coronary plaque among HIV+ than HIV- men. Older age was associated with a greater prevalence of non-calcified plaque in HIV+ men, but not HIV- individuals, in cross-sectional analyses of these 40-70-year old men. To clearly define the progression of coronary plaque in HIV+ treated people, a longitudinal CCTA study is needed. We propose a study to determine whether aging HAART-treated HIV+ men experience greater progression of non-calcified plaque volume than HIV- men. We will also identify plaques with specific features that characterize them as potentially vulnerable (i.e., plaques with low attenuation, outward remodeling, and spotty calcification) and put them at high risk for causing acute coronary syndromes. Emerging evidence suggests that HIV+ persons may be at increased risk for sudden cardiac death (SCD) and heart failure (HF) compared to the general population. We will evaluate left ventricular ejection fraction (EF) and myocardial perfusion abnormalities, since these are known to predispose to CVD events, including SCD and HF, and have not been well studied among HIV+ persons. Thus, this proposal will leverage an existing research infrastructure to achieve the following specific aims: Specific Aim 1: determine whether aging HIV+ men have a greater progression of non-calcified coronary atherosclerotic plaque than HIV- men over 4-6 years of follow-up. Secondary aims are to determine whether, compared to HIV- men, HIV+ men have a) a greater incidence of new non-calcified plaque and/or slower rates of transition from non-calcified to calcified plaque in individual coronary segments and b) a greater prevalence and incidence of high risk vulnerable plaques Specific Aim 2: determine whether HIV+ men are more likely than HIV- men to have myocardial abnormalities that could predispose them to SCD and HF. We will compare a) left ventricular EF and b) global myocardial perfusion index between HIV+ and HIV- men. Secondary aims include a comparison of the prevalences of left ventricular myocardial scar and resting perfusion abnormalities. The proposed studies will lead to a greater understanding of the pathogenesis and dynamics of CVD among HAART-treated HIV+ persons, knowledge which can then be used to develop effective CVD prevention strategies.
描述(由申请人提供):观察性研究表明,与一般人群相比,HIV 感染与心血管疾病 (CVD) 事件的发生率增加相关,包括冠心病和心源性猝死 (SCD);然而,导致这种风险增加的具体机制尚不明确。多中心艾滋病队列研究 (MACS) 是一项针对男男性行为者 (MSM) 的观察性队列研究,其中包括 HIV 感染者 (HIV+) 和未感染者 (HIV-) 参与者。我们通过冠状动脉计算机断层扫描血管造影 (CCTA) 对 MACS 中的 764 名男性进行了亚临床冠状动脉粥样硬化测量。我们发现,与 HIV-男性相比,HIV+男性中非钙化冠状动脉斑块的患病率和范围更大。在对这些 40-70 岁男性的横断面分析中,年龄较大与 HIV+ 男性而非 HIV-个体中非钙化斑块的患病率较高相关。为了清楚地确定 HIV+ 治疗者冠状动脉斑块的进展情况,需要进行纵向 CCTA 研究。我们提出了一项研究,以确定接受HAART治疗的老年HIV阳性男性是否比HIV阴性男性经历了更大的非钙化斑块体积进展。我们还将识别具有特定特征的斑块,这些特征使它们具有潜在的脆弱性(即具有低衰减、向外重塑和斑点钙化的斑块),并将它们置于引起急性冠状动脉综合征的高风险中。新的证据表明,与普通人群相比,艾滋病病毒感染者发生心源性猝死(SCD)和心力衰竭(HF)的风险可能更高。我们将评估左心室射血分数 (EF) 和心肌灌注异常,因为已知这些会导致 CVD 事件,包括 SCD 和 HF,并且尚未在 HIV + 人群中进行充分研究。因此,本提案将利用现有的研究基础设施来实现以下具体目标: 具体目标 1:确定在 4-6 年的随访中,老年 HIV+ 男性的非钙化冠状动脉粥样硬化斑块进展是否比 HIV-男性更大。次要目标是确定与 HIV- 男性相比,HIV+ 男性是否 a) 单个冠状动脉节段中新的非钙化斑块的发生率更高和/或从非钙化斑块向钙化斑块转变的速度更慢,以及 b) 高风险易损斑块的患病率和发生率更高。 具体目标 2:确定 HIV+ 男性是否比 HIV- 男性更有可能出现心肌异常,从而导致心肌异常。 使他们易患 SCD 和 HF。我们将比较 HIV+ 和 HIV- 男性之间的 a) 左心室 EF 和 b) 整体心肌灌注指数。次要目标包括比较左心室心肌疤痕和静息灌注异常的患病率。拟议的研究将有助于更好地了解接受HAART治疗的HIV+患者中CVD的发病机制和动态,这些知识随后可用于制定有效的CVD预防策略。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Coronary Artery Disease in Patients with HIV Infection: An Update.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

WENDY S POST其他文献

WENDY S POST的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('WENDY S POST', 18)}}的其他基金

Progression of Coronary Atherosclerosis in MACS
MACS 中冠状动脉粥样硬化的进展
  • 批准号:
    8790664
  • 财政年份:
    2014
  • 资助金额:
    $ 70.62万
  • 项目类别:
Progression of Coronary Atherosclerosis in MACS
MACS 中冠状动脉粥样硬化的进展
  • 批准号:
    9047317
  • 财政年份:
    2014
  • 资助金额:
    $ 70.62万
  • 项目类别:
Identifying Risk Factors for Subclinical Myocardial Disease in HIV Infection
确定 HIV 感染中亚临床心肌病的危险因素
  • 批准号:
    9330904
  • 财政年份:
    2014
  • 资助金额:
    $ 70.62万
  • 项目类别:
Subclinical Vascular Disease and Metabolic Abnormalities in MACS
MACS 中的亚临床血管疾病和代谢异常
  • 批准号:
    8300148
  • 财政年份:
    2008
  • 资助金额:
    $ 70.62万
  • 项目类别:
Subclinical Vascular Disease and Metabolic Abnormalities in MACS
MACS 中的亚临床血管疾病和代谢异常
  • 批准号:
    7881417
  • 财政年份:
    2008
  • 资助金额:
    $ 70.62万
  • 项目类别:
Subclinical Vascular Disease and Metabolic Abnormalities in MACS
MACS 中的亚临床血管疾病和代谢异常
  • 批准号:
    7691240
  • 财政年份:
    2008
  • 资助金额:
    $ 70.62万
  • 项目类别:
Subclinical Vascular Disease and Metabolic Abnormalities in MACS
MACS 中的亚临床血管疾病和代谢异常
  • 批准号:
    8112655
  • 财政年份:
    2008
  • 资助金额:
    $ 70.62万
  • 项目类别:
LONGEVITY IN THE AMISH
阿米什人的长寿
  • 批准号:
    7604558
  • 财政年份:
    2006
  • 资助金额:
    $ 70.62万
  • 项目类别:
LONGEVITY IN THE AMISH
阿米什人的长寿
  • 批准号:
    7378820
  • 财政年份:
    2005
  • 资助金额:
    $ 70.62万
  • 项目类别:
MESA Family Study
MESA家庭研究
  • 批准号:
    6863298
  • 财政年份:
    2003
  • 资助金额:
    $ 70.62万
  • 项目类别:

相似海外基金

Interplay between Aging and Tubulin Posttranslational Modifications
衰老与微管蛋白翻译后修饰之间的相互作用
  • 批准号:
    24K18114
  • 财政年份:
    2024
  • 资助金额:
    $ 70.62万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
  • 批准号:
    498288
  • 财政年份:
    2024
  • 资助金额:
    $ 70.62万
  • 项目类别:
    Operating Grants
EMNANDI: Advanced Characterisation and Aging of Compostable Bioplastics for Automotive Applications
EMNANDI:汽车应用可堆肥生物塑料的高级表征和老化
  • 批准号:
    10089306
  • 财政年份:
    2024
  • 资助金额:
    $ 70.62万
  • 项目类别:
    Collaborative R&D
関節リウマチ患者のSuccessful Agingに向けたフレイル予防対策の構築
类风湿性关节炎患者成功老龄化的衰弱预防措施的建立
  • 批准号:
    23K20339
  • 财政年份:
    2024
  • 资助金额:
    $ 70.62万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Baycrest Academy for Research and Education Summer Program in Aging (SPA): Strengthening research competencies, cultivating empathy, building interprofessional networks and skills, and fostering innovation among the next generation of healthcare workers t
Baycrest Academy for Research and Education Summer Program in Aging (SPA):加强研究能力,培养同理心,建立跨专业网络和技能,并促进下一代医疗保健工作者的创新
  • 批准号:
    498310
  • 财政年份:
    2024
  • 资助金额:
    $ 70.62万
  • 项目类别:
    Operating Grants
Life course pathways in healthy aging and wellbeing
健康老龄化和福祉的生命历程路径
  • 批准号:
    2740736
  • 财政年份:
    2024
  • 资助金额:
    $ 70.62万
  • 项目类别:
    Studentship
I-Corps: Aging in Place with Artificial Intelligence-Powered Augmented Reality
I-Corps:利用人工智能驱动的增强现实实现原地老龄化
  • 批准号:
    2406592
  • 财政年份:
    2024
  • 资助金额:
    $ 70.62万
  • 项目类别:
    Standard Grant
NSF PRFB FY 2023: Connecting physiological and cellular aging to individual quality in a long-lived free-living mammal.
NSF PRFB 2023 财年:将生理和细胞衰老与长寿自由生活哺乳动物的个体质量联系起来。
  • 批准号:
    2305890
  • 财政年份:
    2024
  • 资助金额:
    $ 70.62万
  • 项目类别:
    Fellowship Award
虚弱高齢者のSuccessful Agingを支える地域課題分析指標と手法の確立
建立区域问题分析指标和方法,支持体弱老年人成功老龄化
  • 批准号:
    23K20355
  • 财政年份:
    2024
  • 资助金额:
    $ 70.62万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
「ケア期間」に着目したbiological aging指標の開発
开发聚焦“护理期”的生物衰老指数
  • 批准号:
    23K24782
  • 财政年份:
    2024
  • 资助金额:
    $ 70.62万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了